Skip to content

David H. Geller, M.D.

NPI 1154350528ActiveIndividual· Specialist· Los Angeles, CA

Specialist (M.D.) in Los Angeles, California, licensed in CA, with an NPI issued in June 2006. Part D covered 11 prescriptions written in 2024. Ascendis Pharma Endocrinology Inc was the largest of 8 companies reporting payments in 2025, $8,970 in all, mostly speaking and faculty fees.

Overview

NPI1154350528
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedJun 30, 2006
Last updated in NPPESNov 20, 2025
Certified by providerNov 20, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (CA)

Part D prescriptions in 2024

Prescriptions (claims)11 · 20 30-day fills
Total drug cost$665.85

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$8,970 · 18 payments from 8 companies
  • 2024$1,766 · 5 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Ascendis Pharma Endocrinology Inc$8,2503
Tolmar, Inc.$341.153
Pfizer Inc.$132.056
Novo Nordisk Inc$125.001
Abbvie Inc.$45.712

What the 2025 payments were for

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$8,224 · 2 payments
  • Food and Beverage$745.94 · 16 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Specialist providers in Los Angeles

All Specialist providers in California →